MELI vs MRNA · P/E 43, rev $19.01B vs rev $145.0M
MercadoLibre Inc. (MELI) versus Moderna Inc (MRNA) — a side-by-side from cached financials, not a winner call.
MercadoLibre Inc. (MELI) is a internet retail company listed on NASDAQ.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ.
Latest reported MELI revenue for 2026-06-30 was $19.01B. Net income was $883.0M. MELI currently screens at market cap $82.73B and trailing P/E 43.1.
Latest reported MRNA revenue for 2026-06-30 was $145.0M. Net income was -$782.0M. Revenue was down 62.7% from 2026-03-31 to 2026-06-30. MRNA currently screens at market cap $24.52B.
MELI currently screens at market cap $82.73B and trailing P/E 43.1. MRNA currently screens at market cap $24.52B.
Not investment advice. Open the MELI and MRNA stock pages for the full models.
Not investment advice.